完整後設資料紀錄
DC 欄位語言
dc.contributor.authorChang, Chia-Mingen_US
dc.contributor.authorLin, Yi-Hsinen_US
dc.contributor.authorSrivastava, Abhishek Kumaren_US
dc.contributor.authorChigrinov, Vladimir Grigorievichen_US
dc.date.accessioned2018-08-21T05:53:24Z-
dc.date.available2018-08-21T05:53:24Z-
dc.date.issued2018-03-09en_US
dc.identifier.issn2045-2322en_US
dc.identifier.urihttp://dx.doi.org/10.1038/s41598-018-22634-wen_US
dc.identifier.urihttp://hdl.handle.net/11536/144652-
dc.description.abstractPhotobiomodulation or low-level light therapy (LLLT) has extensive applications based on light-induced effects in biological systems. Photobiomodulation remains controversial because of a poorly understood biochemical mechanism limited by the well-known biphasic dose response or Arndt-Schulz curve. The Arndt-Schulz curve states that an optimal dose of light is a key factor for realizing a therapeutic effect. In this report, we demonstrate a tunable optical system for photobiomodulation to aid physicians in overcoming the constraints of light due to biphasic dose response. The tunable optical system is based on a white light-emitting diode and four liquid crystal (LC) photonic devices: three LC phase retarders, and one LC lens. The output light of the tunable optical system exhibits electrical tunability for the wavelength, energy density and beam size. The operating principle is introduced, and the experimental results are presented. The proposed concept can be further extended to other electrically tunable photonic devices for different clinical purposes for photobiomodulation.en_US
dc.language.isoen_USen_US
dc.titleAn optical system via liquid crystal photonic devices for photobiomodulationen_US
dc.typeArticleen_US
dc.identifier.doi10.1038/s41598-018-22634-wen_US
dc.identifier.journalSCIENTIFIC REPORTSen_US
dc.citation.volume8en_US
dc.contributor.department光電工程學系zh_TW
dc.contributor.departmentDepartment of Photonicsen_US
dc.identifier.wosnumberWOS:000427021000001en_US
顯示於類別:期刊論文